Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Schedule of Summarizes Information About Stock Options (Details)

v3.19.3
Stock-Based Compensation - Schedule of Summarizes Information About Stock Options (Details)
9 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
shares
2014 Long Term Incentive Equity Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Stock Options Outstanding, Beginning Balance 3,327,140
Number of Stock Options, Granted 1,875,000
Number of Stock Option, Exercised
Number of Stock Option, Forfeited (48,611)
Number of Stock Options Outstanding, Ending Balance 5,153,529
Number of Stock Options Vested and exercisable 2,942,544
Number of Stock Options Unvested 2,210,985
Weighted-Average Exercise Price, Beginning Balance | $ / shares $ 3.68
Weighted-Average Exercise Price, Granted | $ / shares 1.00
Weighted-Average Exercise Price, Exercised | $ / shares
Weighted-Average Exercise Price, Forfeited | $ / shares 5.00
Weighted-Average Exercise Price, Ending Balance | $ / shares 2.70
Weighted-Average Exercise Price, Vested and exercisable | $ / shares 3.62
Weighted-Average Exercise Price, Unvested | $ / shares $ 1.46
Aggregate Intrinsic Value Outstanding | $
Aggregate Intrinsic Value Outstanding | $
Aggregate Intrinsic Value Vested and exercisable | $
Aggregate Intrinsic Value Unvested | $
2018 Stock Plan [Member] | Lucid Diagnostics Inc [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Stock Options Outstanding, Beginning Balance 375,000
Number of Stock Options, Granted 620,000
Number of Stock Option, Exercised
Number of Stock Option, Forfeited
Number of Stock Options Outstanding, Ending Balance 995,000
Number of Stock Options Vested and exercisable 441,246
Number of Stock Options Unvested 553,754
Weighted-Average Exercise Price, Beginning Balance | $ / shares $ 0.60
Weighted-Average Exercise Price, Granted | $ / shares 1.02
Weighted-Average Exercise Price, Exercised | $ / shares
Weighted-Average Exercise Price, Ending Balance | $ / shares 0.86
Weighted-Average Exercise Price, Vested and exercisable | $ / shares 0.83
Weighted-Average Exercise Price, Unvested | $ / shares $ 0.88
Vested and exercisable stock options, Remaining Contractual Term (Years) 9 years 2 months 12 days
Unvested stock options, Remaining Contractual Term (Years) 9 years 1 month 6 days